Since a new drug came out that's almost the same as your company's for such a cheap price, how do expect to turn a profit now?
[–]martinshkreli[S] 0 points 16 hours ago
no new drug is FDA approved for toxoplasmosis.
[–]LouisDeFeo 1 point 16 hours ago
You're right, excuse me. I meant when it gets approved, how do you expect to turn a profit?
[–]martinshkreli[S] 0 points 16 hours ago
they're not going to do that. they don't have the resources.
and:
[–]strik3three 2 points 16 hours ago
You've said the rise in the cost of Daraprim won't effect most patients because the insurance companies will absorb the cost. Does it not stand to reason though that the insurance companies will pass those cost back along to the policy holders who pay the premiums. How does that argument not perpetuate the problem of out of control medical cost?
[–]martinshkreli[S] -1 points 16 hours ago
It definitely stands to reason. But the other thing to consider is that as more companies generate revenue and profits new companies sprout to compete with them for that profit pool. This keeps costs down.
and:
[–]HomerPepsi 1 point 12 hours ago
Money aside, how do you feel about being hated by the world?
[–]martinshkreli[S] 0 points 5 hours ago
It doesn't bother me. My priority is patients and I have a ton of support from them. I don't answer to the media or random internet crazies.
And the winner (appeal to common practice fallacy):
Since a new drug came out that's almost the same as your company's for such a cheap price, how do expect to turn a profit now?
[–]martinshkreli[S] 0 points 16 hours ago
no new drug is FDA approved for toxoplasmosis.
[–]LouisDeFeo 1 point 16 hours ago
You're right, excuse me. I meant when it gets approved, how do you expect to turn a profit?
[–]martinshkreli[S] 0 points 16 hours ago
they're not going to do that. they don't have the resources.
[–]strik3three 2 points 16 hours agoYou've said the rise in the cost of Daraprim won't effect most patients because the insurance companies will absorb the cost. Does it not stand to reason though that the insurance companies will pass those cost back along to the policy holders who pay the premiums. How does that argument not perpetuate the problem of out of control medical cost?
[–]martinshkreli[S] -1 points 16 hours ago
It definitely stands to reason. But the other thing to consider is that as more companies generate revenue and profits new companies sprout to compete with them for that profit pool. This keeps costs down.
[–]HomerPepsi 1 point 12 hours agoMoney aside, how do you feel about being hated by the world?
[–]martinshkreli[S] 0 points 5 hours ago
It doesn't bother me. My priority is patients and I have a ton of support from them. I don't answer to the media or random internet crazies.
https://twitter.com/MartinShkreli/status/656180089747611651